- Home
- FTHY vs ZVRA Comparison
FTHY vs ZVRA Comparison
Compare FTHY & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FTHY | ZVRA |
|---|---|---|
| Founded | 2020 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 539.8M | 499.9M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | FTHY | ZVRA |
|---|---|---|
| Price | $13.99 | $8.27 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.71 |
| AVG Volume (30 Days) | 176.7K | ★ 1.1M |
| Earning Date | 01-01-0001 | 11-05-2025 |
| Dividend Yield | ★ 10.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.54 |
| Revenue | N/A | ★ $84,388,000.00 |
| Revenue This Year | N/A | $333.25 |
| Revenue Next Year | N/A | $43.70 |
| P/E Ratio | ★ N/A | $15.46 |
| Revenue Growth | N/A | ★ 244.60 |
| 52 Week Low | $12.66 | $6.19 |
| 52 Week High | $14.74 | $13.16 |
Technical Indicators
Market Signals| Indicator | FTHY | ZVRA |
|---|---|---|
| Relative Strength Index (RSI) | 46.40 | 40.42 |
| Support Level | $13.90 | $8.05 |
| Resistance Level | $14.05 | $8.32 |
| Average True Range (ATR) | 0.08 | 0.33 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 33.33 | 25.00 |
Price Performance
Historical ComparisonAbout FTHY First Trust High Yield Opportunities 2027 Term Fund
FIRST TRUST HIGH YIELD OPPORTUNITIES 2027 TERM FUND is a diversified, closed-end management investment company. The investment objective of the fund is to provide current income. The fund invests a majority of its managed assets in high-yield debt securities of any maturity that are rated below investment grade at the time of purchase or unrated securities. Its investment portfolio comprises corporate bonds and notes, senior floating-rate loan interests, foreign corporate bonds and notes, money market funds, and other instruments across various industries.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.